[go: up one dir, main page]

HK1245822A1 - 一种经修饰的dnase及其应用 - Google Patents

一种经修饰的dnase及其应用 Download PDF

Info

Publication number
HK1245822A1
HK1245822A1 HK18104094.7A HK18104094A HK1245822A1 HK 1245822 A1 HK1245822 A1 HK 1245822A1 HK 18104094 A HK18104094 A HK 18104094A HK 1245822 A1 HK1245822 A1 HK 1245822A1
Authority
HK
Hong Kong
Prior art keywords
protein
dnase
modified
modified dnase
dna
Prior art date
Application number
HK18104094.7A
Other languages
English (en)
Inventor
Lilach CHEN ZELTSBURG
Ilya Ruderfer
Avidor Shulman
Liat Fux
Yulia UGORTSEV
Hagit NETA
Sivan GELLEY
Elad LAVEE LAVIAD
Yoseph Shaaltiel
Original Assignee
Protalix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protalix Ltd filed Critical Protalix Ltd
Publication of HK1245822A1 publication Critical patent/HK1245822A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
    • C12Y301/21001—Deoxyribonuclease I (3.1.21.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK18104094.7A 2015-01-04 2016-01-04 一种经修饰的dnase及其应用 HK1245822A1 (zh)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201562099565P 2015-01-04 2015-01-04
US201562099560P 2015-01-04 2015-01-04
US201562099560P 2015-01-04
US201562099565P 2015-01-04
US201562163497P 2015-05-19 2015-05-19
US201562163497P 2015-05-19
US201562169724P 2015-06-02 2015-06-02
US201562169724P 2015-06-02
US201562247856P 2015-10-29 2015-10-29
US201562247856P 2015-10-29
PCT/IL2016/050003 WO2016108244A1 (en) 2015-01-04 2016-01-04 Modified dnase and uses thereof

Publications (1)

Publication Number Publication Date
HK1245822A1 true HK1245822A1 (zh) 2018-08-31

Family

ID=55442842

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18104094.7A HK1245822A1 (zh) 2015-01-04 2016-01-04 一种经修饰的dnase及其应用

Country Status (13)

Country Link
US (2) US11225648B2 (zh)
EP (1) EP3240896A1 (zh)
CN (1) CN107406837A (zh)
AU (1) AU2016204793B2 (zh)
BR (1) BR112017014433A2 (zh)
CA (1) CA2970216A1 (zh)
HK (1) HK1245822A1 (zh)
IL (1) IL253208B2 (zh)
MX (1) MX395742B (zh)
NZ (1) NZ733912A (zh)
RU (1) RU2017125957A (zh)
WO (1) WO2016108244A1 (zh)
ZA (1) ZA201704903B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1245822A1 (zh) 2015-01-04 2018-08-31 Protalix Ltd 一种经修饰的dnase及其应用
TWI788307B (zh) 2016-10-31 2023-01-01 美商艾歐凡斯生物治療公司 用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
BR112019009925A2 (pt) 2016-11-17 2019-10-08 Iovance Biotherapeutics Inc método para preparar linfócitos infiltrantes de tumor remanescente para terapia de células t adotivas, e, método de tratamento de um câncer .
JP2021510539A (ja) 2018-01-16 2021-04-30 シーエルエス セラピューティクス リミテッドＣＬＳ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ デオキシリボヌクレアーゼ（ＤＮａｓｅ）活性を有する酵素の肝臓発現による疾患の処置
EP3821003A4 (en) * 2018-07-09 2022-07-20 Gro Biosciences Inc. Non-standard amino acid containing compositions and uses thereof
WO2020106709A1 (en) * 2018-11-19 2020-05-28 Gro Biosciences Inc. Human dnase for lung disease
WO2020198452A1 (en) * 2019-03-26 2020-10-01 Medicinal Genomics Corporation Methods of detecting microbial content in cannabis
JP2023545740A (ja) 2020-10-07 2023-10-31 プロタリクス リミテッド 長期活性ＤＮａｓｅ
WO2022178078A1 (en) 2021-02-19 2022-08-25 Theripion, Inc. Paraoxonase fusion polypeptides and related compositions and methods

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
ES2130120T3 (es) * 1988-12-23 1999-07-01 Genentech Inc Procedimiento para la preparacion de la adnasa humana.
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5394866A (en) 1991-03-05 1995-03-07 Aradigm Corporation Automatic aerosol medication delivery system and methods
DE69333443T2 (de) 1992-04-09 2005-03-24 Omron Healthcare Co., Ltd. Ultraschallzerstäuber
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5694919A (en) 1993-01-29 1997-12-09 Aradigm Corporation Lockout device for controlled release of drug from patient-activated dispenser
US5507277A (en) 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5888477A (en) 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
JP3009224B2 (ja) * 1994-03-04 2000-02-14 ジェネンテック インコーポレイテッド 改良されたｄｎアーゼ液体溶液
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US5509404A (en) 1994-07-11 1996-04-23 Aradigm Corporation Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
SK284191B6 (sk) * 1995-02-24 2004-10-05 Genentech, Inc. Aktín-rezistentný variant humánnej DNázy I
US6348343B2 (en) * 1995-02-24 2002-02-19 Genentech, Inc. Human DNase I variants
US6391607B1 (en) * 1996-06-14 2002-05-21 Genentech, Inc. Human DNase I hyperactive variants
GB2316323B (en) 1996-06-20 1999-09-22 Aid Medic Ltd Dispensing system
AU6014098A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems Aerosolized hydrophobic drug
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
GB9903433D0 (en) 1999-02-15 1999-04-07 The Technology Partnership Plc Droplet generation method and device
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DE10013093B4 (de) 2000-03-17 2005-12-22 Inamed Gmbh Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole
EP1249244A1 (en) 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
DE10123749A1 (de) 2001-05-16 2002-12-12 Inamed Gmbh Vorrichtung zum Verabreichen von Aerosolen
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030044493A1 (en) 2001-06-28 2003-03-06 Rettey David C. Container comprising edible manifold
RU2269356C2 (ru) 2003-07-14 2006-02-10 Дмитрий Дмитриевич Генкин Способ лечения онкологических заболеваний
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
WO2006130034A1 (fr) 2005-04-25 2006-12-07 Dmitry Dmitrievich Genkin Procede pour prolonger la duree de vie d'animaux ou de l'humain
WO2006006963A2 (en) 2004-04-02 2006-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Aerosol delivery systems and methods
WO2007131108A2 (en) 2006-05-03 2007-11-15 Tmi Laboratories International, Inc. Method to diagnose and increase fertility of mammalian semen using dnase as diagnostic marker and therapeutic agent
US20080131497A1 (en) 2006-09-28 2008-06-05 Perkins Walter R Formulations of DNase and Methods of Use Thereof
PT2086642E (pt) 2006-10-18 2014-09-30 Periness Ltd Dnase para o tratamento de subfertilidade masculina
US8871200B2 (en) 2006-11-28 2014-10-28 Cls Therapeutics Limited Method for treating human diseases associated with an increased deoxyribonucleic acid content in extracellular spaces of tissues and a medicinal preparation for carrying out said method
WO2011004476A1 (ja) 2009-07-09 2011-01-13 パイオニア株式会社 スピーカ装置
US20150010527A1 (en) 2012-02-01 2015-01-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
HK1245822A1 (zh) 2015-01-04 2018-08-31 Protalix Ltd 一种经修饰的dnase及其应用

Also Published As

Publication number Publication date
CA2970216A1 (en) 2016-07-07
US20220106578A1 (en) 2022-04-07
CN107406837A (zh) 2017-11-28
BR112017014433A2 (pt) 2018-05-15
AU2016204793B2 (en) 2021-12-16
IL253208B2 (en) 2023-03-01
WO2016108244A1 (en) 2016-07-07
ZA201704903B (en) 2023-10-25
US11225648B2 (en) 2022-01-18
US11814657B2 (en) 2023-11-14
NZ733912A (en) 2023-04-28
MX395742B (es) 2025-03-25
AU2016204793A1 (en) 2017-08-10
US20180112201A1 (en) 2018-04-26
IL253208B (en) 2022-11-01
EP3240896A1 (en) 2017-11-08
RU2017125957A (ru) 2019-02-04
MX2017008567A (es) 2018-04-26
IL253208A0 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
HK1245822A1 (zh) 一种经修饰的dnase及其应用
Reber et al. Potential effector and immunoregulatory functions of mast cells in mucosal immunity
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2016046234A3 (en) Recombinant phe-free proteins for use in the treatment of phenylketonuria
WO2015191666A3 (en) Raf1 fusions
WO2017015622A8 (en) Gdf11 binding proteins and uses thereof
EP4445870A3 (en) Ophthalmic devices, system and methods that improve peripheral vision
EP3009505A4 (en) Recombinant strain producing l-amino acids, constructing method therefor and method for producing l-amino acids.
MX2016003945A (es) Composiciones y formulaciones para la prevencion y tratamiento de la diabetes y la obesidad y los metodos de produccion y uso en el control de la glucosa y calorias.
BR112016017041A2 (pt) Proteína isolada tendo atividade de fosfatase, polinucleotídeo, vetor, célula hospedeira, método para produzir uma proteína e composição
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
HK1246097A1 (zh) 含有壳多糖和可消化蛋白的组合物
LT3538066T (lt) Hialurono rūgšties odos užpildai kryžmiškai susieti su citrinos rūgštimi, jų gaminimo būdas ir panaudojimas
EP3207940A4 (en) Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
MX2017009937A (es) Cepas fungicas y metodos de uso.
WO2016070206A3 (de) Polypeptid zur enzymatischen detoxifizierung von zearalenon, sowie isoliertes polynukleotid, sowie zusatzstoff, verwendung und verfahren desselben
BR112018007474A2 (pt) ?limpeza de membranas de filtração de água?
WO2017151860A8 (en) Human kynureninase enzyme variants having improved pharmacological properties
EP4501949A3 (en) Pneumolysin mutants and methods of use thereof
TW201613631A (en) Ghrelin secretion promoter
MY197890A (en) Mutant strains of trichoderma reesei
EP3217974A4 (en) Method for treating, preventing, or reducing the risk of skin infection
EP4067485A3 (en) Lipase variants and polynucleotides encoding same
CA2986376C (en) Poxvirus-derived promoter, and vector comprising same
WO2016103042A8 (en) Compositions and methods for inhibiting expression of adamts-5 and adam17